Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01520987 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetics of BIA 9-1067 in Healthy Japanese and Caucasian Subjects
A Phase 1 study, sponsored by Bial - Portela C S.A..
- Completed
- Registry status
- Phase 1
- Development phase
- 105
- Enrollment target
NCT01520987 is a Phase 1 study that has completed, run by Bial - Portela C S.A.. The registered enrollment target is 105 participants.
The verdict
NCT01520987, a Phase 1 study, has completed, sponsored by Bial - Portela C S.A..
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 105 participants
- Enrollment target
Study Summary
To assess the pharmacokinetics of BIA 9-1067 in healthy Japanese subjects
Interventions
- DRUG Placebo
- DRUG BIA 9-1067
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2011-05 |
| Est. Completion | 2012-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01520987
The ClinicalTrials.gov registry entry for NCT01520987 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bial - Portela C S.A., which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01520987 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01520987 about?
NCT01520987 is a clinical study titled "Pharmacokinetics of BIA 9-1067 in Healthy Japanese and Caucasian Subjects". To assess the pharmacokinetics of BIA 9-1067 in healthy Japanese subjects
What is the current status of trial NCT01520987?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 105 participants. The study started on 2011-05. Estimated completion is 2012-11.
What interventions are being tested in trial NCT01520987?
The interventions under investigation include: Placebo (DRUG), BIA 9-1067 (DRUG).
Who is sponsoring clinical trial NCT01520987?
This trial is sponsored by Bial - Portela C S.A., which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.